235 related articles for article (PubMed ID: 12531084)
1. Prevention of bronchiolitis.
Pringle CR
Paediatr Respir Rev; 2000 Sep; 1(3):228-34. PubMed ID: 12531084
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with respiratory syncytial virus vaccines.
Piedra PA
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
[TBL] [Abstract][Full Text] [Related]
3. Prevention strategies for respiratory syncytial virus: passive and active immunization.
Englund JA
J Pediatr; 1999 Aug; 135(2 Pt 2):38-44. PubMed ID: 10431138
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus infections: characteristics and treatment.
Chidgey SM; Broadley KJ
J Pharm Pharmacol; 2005 Nov; 57(11):1371-81. PubMed ID: 16259768
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus immune globulin: decisions and costs.
Barton LL; Grant KL; Lemen RJ
Pediatr Pulmonol; 2001 Jul; 32(1):20-8. PubMed ID: 11416872
[TBL] [Abstract][Full Text] [Related]
7. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.
Bont L; Kimpen JL
Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411
[TBL] [Abstract][Full Text] [Related]
8. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
[TBL] [Abstract][Full Text] [Related]
9. [Current news about epidemiology of syncytial respiratory virus infection].
Palumbo E
Recenti Prog Med; 2008 May; 99(5):237-9. PubMed ID: 18581965
[TBL] [Abstract][Full Text] [Related]
10. Passive immunisation of preterm infants with palivizumab against RSV infection.
Harkensee C; Brodlie M; Embleton ND; Mckean M
J Infect; 2006 Jan; 52(1):2-8. PubMed ID: 16236360
[TBL] [Abstract][Full Text] [Related]
11. Immunoprophylaxis of respiratory syncytial virus infection.
Simoes EA
Indian Pediatr; 2000 Mar; 37(3):243-7. PubMed ID: 10750065
[No Abstract] [Full Text] [Related]
12. Advances in the treatment and prevention of severe viral bronchiolitis.
Domachowske JB; Rosenberg HF
Pediatr Ann; 2005 Jan; 34(1):35-41. PubMed ID: 15693214
[TBL] [Abstract][Full Text] [Related]
13. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
14. Prevention of respiratory syncytial virus infection in infants.
Handforth J; Sharland M; Friedland JS
BMJ; 2004 May; 328(7447):1026-7. PubMed ID: 15117767
[No Abstract] [Full Text] [Related]
15. Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab.
Fitzgerald DA
Paediatr Respir Rev; 2009 Sep; 10(3):143-7. PubMed ID: 19651385
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus infections: recent prospects for control.
Sidwell RW; Barnard DL
Antiviral Res; 2006 Sep; 71(2-3):379-90. PubMed ID: 16806515
[TBL] [Abstract][Full Text] [Related]
17. Palivizumab in the prophylaxis of respiratory syncytial virus infection.
Cardenas S; Auais A; Piedimonte G
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):719-26. PubMed ID: 16207163
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab.
Reeve CA; Whitehall JS; Buettner PG; Norton R; Reeve DM; Francis F
J Paediatr Child Health; 2006 May; 42(5):253-8. PubMed ID: 16712554
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.
Johnson TR
Expert Rev Vaccines; 2006 Jun; 5(3):371-80. PubMed ID: 16827621
[TBL] [Abstract][Full Text] [Related]
20. Statement on the recommended use of monoclonal anti-RSV antibody (palivizumab).
National Advisory Committee on Immunization
Can Commun Dis Rep; 2003 Sep; 29():1-15. PubMed ID: 14524195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
